Advertisement

Picture Kentro Design Corporate and Web Design Berlin 600x60px

News > All

Total search results: 16888 | Ordered by Date (descending)
1 2 3 ... 167 168 169  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Tecan Group Ltd.. (1/15/19). "Press Release: Achim von Leoprechting Promoted to Become CEO of Tecan after Retirement of David Martyr". Männedorf. 2019-01-15
Minoryx Therapeutics S.L.. (1/15/19). "Press Release: Minoryx Therapeutics Extends Its Activities in Belgium". Mataró, Barcelona & Charleroi. 2019-01-15
Phico Therapeutics Ltd.. (1/15/19). "Press Release: Phico Therapeutics Appoints Financial Director and Two Non-Executives". Cambridge. 2019-01-15
[iito] Business Intelligence. (1/11/19). "Press Release: [iito] Discontinues Life-Sciences-UK.com and Life-Sciences-France.com. All Data Will Still Be Available at Life-Sciences-Europe.com". Bremen. 2019-01-11
Samplix ApS. (1/10/19). "Press Release: Samplix Wins €1.9 Million in Prestigious Horizon 2020 – SME Instrument Program". 2019-01-10
Sirion Biotech GmbH. (1/9/19). "Press Release: Sirion Biotech and Denali Therapeutics Join Forces to Develop Gene Therapies for Diseases of the Central Nervous System". Munich. 2019-01-09
Selexis S.A.. (1/9/19). "Press Release: Selexis Expands Strategic Immuno-Oncology Alliance with Agenus". Geneva. 2019-01-09
c-LEcta GmbH. (1/9/19). "Press Release: c-LEcta Announces Two Long-term Industry Collaborations". 2019-01-09
GreenLight Biosciences, Inc.. (1/8/19). "Press Release: GreenLight Biosciences Announces $50 Million Funding Round". Medford, MA. 2019-01-08
Evotec AG. (1/7/19). "Press Release: Evotec Invests in Financing Round of Exscientia". Hamburg. 2019-01-07
Qiagen N.V.. (1/7/19). "Press Release: Qiagen Acquires N-of-One, Expanding Its Clinical Bioinformatics Capabilities in Molecular Oncology Decision Support". Redwood City, CA & Hilden. 2019-01-07
Qiagen N.V.. (1/7/19). "Press Release: Qiagen Unveils Plans for Next-generation Digital PCR Systems". Hilden & Germantown, MD. 2019-01-07
Exscientia Ltd.. (1/7/19). "Press Release: Exscientia Raises US$26 Million in Series B Financing Round to Accelerate Scaling as the Leading AI Drug Discovery Company". 2019-01-07
Alligator Bioscience AB. (1/7/19). "Press Release: Alligator Bioscience Launches RUBY, a Novel Concept in Bispecific Antibody Formats". Lund. 2019-01-07
AstraZeneca plc. (1/7/19). "Press Release: AstraZeneca Announces Organisational Changes". 2019-01-07
Eli Lilly and Company. (1/7/19). "Press Release: Lilly Announces Agreement to Acquire Loxo Oncology". Indianapolis, IN & Stamford, CT. 2019-01-07
Valneva S.E.. (1/7/19). "Press Release: Valneva Announces Its Intention to Delist from the Vienna Stock Exchange. Trading Will Be Centralized on Euronext Paris". Saint-Herblain. 2019-01-07
F2G Ltd.. (1/7/19). "Press Release: F2G Expands Investor Syndicate and Progresses Phase IIb Study for Novel Antifungal". Manchester. 2019-01-07
Immunic AG. (1/7/19). "Press Release: Vital Therapies and Immunic Therapeutics Announce Transaction to Create Leading Inflammatory and Autoimmune Disease Company". San Diego, CA & Planegg-Martinsried. 2019-01-07
Orchard Therapeutics Ltd.. (1/7/19). "Press Release: Orchard Therapeutics Highlights Recent Accomplishments and 2019 Strategic Priorities as a Global Leader in Gene Therapy". Boston & London. 2019-01-07
10x Genomics Inc.. (1/7/19). "Press Release: 10x Genomics Lands New Financing". Pleasanton, CA. 2019-01-07
Sanofi S.A.. (1/7/19). "Press Release: Sanofi and Regeneron Restructure Immuno-Oncology Collaboration for Discovery and Development Programs". Paris & Tarrytown, NY. 2019-01-07
Keros Therapeutics, Inc.. (1/7/19). "Press Release: Keros Therapeutics Receives $23 Million Series B Funding for Development of Therapies to Treat Debilitating Neuromuscular Diseases". Lexington, MA. 2019-01-07
Valneva S.E.. (1/7/19). "Press Release: Valneva Reports Positive Phase 1 Interim Results for Its Chikungunya Vaccine Candidate". Saint-Herblain. 2019-01-07
Exscientia Ltd.. (1/7/19). "Press Release: Exscientia Initiates Sixth AI Drug Discovery Partnership". 2019-01-07
Immunocore Ltd.. (1/4/19). "Press Release: Immunocore Appoints Bahija Jallal as Chief Executive Officer". Oxford & Conshohocken, PA. 2019-01-04
CRISPR Therapeutics AG. (1/4/19). "Press Release: CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Sickle Cell Disease". Zug, Cambridge, MA & Boston, MA. 2019-01-04
Oculis S.A.. (1/4/19). "Press Release: Oculis Raises CHF15.5 Million in an Extension of Its Series B Financing Round – Total Raised CHF35.5 Million". Lausanne. 2019-01-04
BioNTech AG. (1/4/19). "Press Release: Sanofi Invests EUR 80m (approx. USD 91.5m) in BioNTech as Partners Extend Collaboration and Advance mRNA-based Cancer Immunotherapy into Clinical Testing against Multiple Solid Tumors". Mainz. 2019-01-04
BioNTech AG. (1/4/19). "Press Release: BioNTech Announces Corporate Form Transition from AG to SE; Welcomes Ryan Richardson as Senior Vice President Corporate Development and Strategy and Appoints Dr. Ulrich Wandschneider as Member of Supervisory Board". 2019-01-04
Oculis S.A.. (1/4/19). "Press Release: Oculis Expands Portfolio with the In-Licensing of a Novel Phase II-stage Anti-TNF alpha Antibody Fragment". Lausanne. 2019-01-04
Sophia Genetics S.A.. (1/4/19). "Press Release: Sophia Genetics Raises $77 Million to Accelerate the Democratization of Data-Driven Medicine". San Francisco, CA. 2019-01-04
Galapagos N.V.. (1/4/19). "Press Release: Fibrocor and Galapagos Sign Partnership in Fibrosis". Mechelen. 2019-01-04
Ribon Therapeutics, Inc.. (1/4/19). "Press Release: Ribon Therapeutics Raises $65 Million to Advance Pipeline of Novel Therapeutics Targeting Cellular Stress Pathways for Cancer". Lexington, MA. 2019-01-04
Boehringer Ingelheim. (1/4/19). "Press Release: Boehringer Ingelheim Exercises Option on Second Hepatic Disease Target From Research Collaboration with Dicerna". Ingelheim & Cambridge, MA. 2019-01-04
Medigene AG. (1/4/19). "Press Release: Medigene Licenses Co-stimulator to Enhance TCR Therapies for Solid Tumors". Planegg. 2019-01-04
Boehringer Ingelheim. (1/3/19). "Press Release: Boehringer Ingelheim Initiates a Collaborative Partnership with Science 37 to Accelerate Patient Centricity in the Development of Novel Therapies". Ingelheim & Playa Vista, CA. 2019-01-03
UroGen Pharma Ltd.. (1/3/19). "Press Release: UroGen Pharma Appoints Elizabeth (Liz) Barrett as President and Chief Executive Officer". New York, NY. 2019-01-03
Atriva Therapeutics GmbH. (1/3/19). "Press Release: Atriva Therapeutics Announces First Closing of Series A Financing Round". Tübingen. 2019-01-03
Immatics Biotechnologies GmbH. (1/3/19). "Press Release: US Patent Office Grants the 100th Patent to Immatics Underpinning the Company’s Leading Role in the Field of Innovative Immunotherapies". Munich. 2019-01-03
Bristol-Myers Squibb Company. (1/3/19). "Press Release: Bristol-Myers Squibb to Acquire Celgene to Create a Premier Innovative Biopharma Company". New York, NY & Summit, NJ. 2019-01-03
Boehringer Ingelheim. (1/3/19). "Press Release: Boehringer Ingelheim and Vanderbilt University Announce Partnership to Develop Novel Therapies for Psychiatric Disorders". Nashville, TN & Ingelheim. 2019-01-03
ProBioGen AG. (1/3/19). "Press Release: ProBioGen’s GlymaxX ADCC Enhancement Technology Used by Betta Pharmaceuticals". Berlin. 2019-01-03
Verily Life Sciences. (1/3/19). "Press Release: Verily Announces $1 Billion Investment Round to Fund Growth and Innovation". South San Francisco, CA. 2019-01-03
InflaRx N.V.. (1/3/19). "Press Release: InflaRx Continues U.S. Expansion with Addition of New York City Corporate Office and Addition of Management". Jena & New York, NY. 2019-01-03
Hookipa Pharma Inc.. (1/2/19). "Press Release: Hookipa Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead". New York, NY & Vienna. 2019-01-02
Vedanta Biosciences. (12/24/18). "Press Release: Vedanta Biosciences Raises $27 Million Series C Financing to Advance Clinical Pipeline of Microbiome-Derived Product Candidates". Cambridge, MA. 2018-12-24
Novartis AG. (12/21/18). "Press Release: Novartis Successfully Completes Acquisition of Endocyte". Basel. 2018-12-21
Nabriva Therapeutics plc. (12/21/18). "Press Release: Nabriva Therapeutics Announces Closing of up to a $75 million Term Loan". Dublin. 2018-12-21
Valneva S.E.. (12/21/18). "Press Release: Valneva Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate". Saint-Herblain. 2018-12-21
Bruker Corporation. (12/20/18). "Press Release: Bruker Comments on Block Trade Transaction". Billerica, MA. 2018-12-20
Novartis AG. (12/20/18). "Press Release: Novartis Announces New CEO of Oncology Business Unit". Basel. 2018-12-20
Novartis AG. (12/20/18). "Press Release: Novartis Announces Offer to Acquire CellforCure to Expand Manufacturing Capacity for Innovative Cell and Gene Therapies". Basel. 2018-12-20
SHS Gesellschaft für Beteiligungsmanagement mbH. (12/20/18). "Press Release: SHS Invests in Swiss Life Science Company Evitria AG". Tübingen & Schlieren. 2018-12-20
Nabriva Therapeutics plc. (12/20/18). "Press Release: Nabriva Therapeutics Submits New Drug Applications to U.S. Food and Drug Administration for Intravenous and Oral Lefamulin to Treat Community-Acquired Bacterial Pneumonia in Adults". Dublin. 2018-12-20
Morphogen-IX Ltd.. (12/20/18). "Press Release: Morphogen-IX Raises £18.4M ($23.2M) in a Series B Financing". Cambridge. 2018-12-20
Annexon Biosciences. (12/19/18). "Press Release: Annexon Biosciences Closes $75 Million Financing". South San Francisco, CA. 2018-12-19
Medigene AG. (12/19/18). "Press Release: Medigene Publishes Topline Interim Data from Ongoing Phase I/II Clinical Trial with DC Vaccines in AML Patients". Martinsried. 2018-12-19
Altheia Science S.r.l.. (12/19/18). "Press Release: Altheia Science Announced the Final Closing of the Series A Capital Raise Banking $19.3M (€17M), Well Above the Initial Target of $11.4M (€10M)". Milano & New York, NY. 2018-12-19
Cellestia Biotech AG. (12/19/18). "Press Release: Cellestia Biotech AG Successfully Closes Series A Financing Round, Raising a Total of CHF 20 Million". Basel. 2018-12-19
Protagen AG. (12/18/18). "Press Release: Protagen AG Appoints Immuno-Oncology Experts to Its Scientific Advisory Board". 2018-12-18
Bruker Corporation. (12/18/18). "Press Release: Bruker Completes the Acquisition of Alicona Imaging GmbH". Billerica, MA. 2018-12-18
Curetis N.V.. (12/18/18). "Press Release: Curetis’ Subsidiary Ares Genetics Teams Up with Leading Global Pharma Company in Fight Against Antibiotic Resistance". Vienna, Holzgerlingen & Amsterdam. 2018-12-18
Sanofi S.A.. (12/18/18). "Press Release: Sanofi to Transfer U.S. Stock Exchange Listing to Nasdaq". Paris. 2018-12-18
High-Tech Gründerfonds Management GmbH. (12/18/18). "Press Release: High-Tech Gründerfonds and Think.Health Ventures together with Business Angels Invest 3.3 Million Euros in a Series A for the Growth of PreOmics in Martinsried, Germany". 2018-12-18
Amgen Inc.. (12/18/18). "Press Release: Amgen and Molecular Partners Announce Strategic Collaboration In Immuno-Oncology". Thousand Oaks, CA & Schlieren. 2018-12-18
Selexis S.A.. (12/17/18). "Press Release: TeneoBio and Selexis Enter Second Services Agreement to Develop Research Cell Banks". Geneva & Menlo Park, CA. 2018-12-17
Novo Nordisk A/S. (12/17/18). "Press Release: Staten Biotechnology B.V. and Novo Nordisk A/S Announce Collaboration to Develop Novel Treatment for Dyslipidaemia". Nijmegen & Copenhagen. 2018-12-17
Versant Ventures. (12/17/18). "Press Release: Versant Ventures Raises $700 Million". San Francisco, CA, New York, NY & Vancouver, BC. 2018-12-17
Valneva S.E.. (12/17/18). "Press Release: Valneva Initiates Phase 2 Clinical Development For Its Lyme Disease Vaccine Candidate". Saint-Herblain. 2018-12-17
Hookipa Pharma Inc.. (12/17/18). "Press Release: Hookipa Doses First Patient in a Phase 2 Clinical Trial of Prophylactic Vaccine Candidate HB-101 against Cytomegalovirus". New York, NY & Vienna. 2018-12-17
Mobidiag Oy. (12/17/18). "Press Release: Mobidiag Announces Joint Venture with Autobio Diagnostics and €10m Equity Investment". Espoo. 2018-12-17
Carmat S.A.. (12/17/18). "Press Release: The European Investment Bank Supports Carmat with €30 Million for the Marketing Process of Its Total Artificial Heart". Paris. 2018-12-17
Galapagos N.V.. (12/17/18). "Press Release: Galapagos Reports Initiation of ISABELA Phase 3 Program with GLPG1690 in Patients with Idiopathic Pulmonary Fibrosis (IPF)". Mechelen. 2018-12-17
OncoImmunity AS. (12/17/18). "Press Release: OncoImmunity Receives €2.2 Million to Roll Out Its Machine-learning Platform to Enable the Development of Personalized Cancer Immunotherapies". Oslo. 2018-12-17
Seer, Inc.. (12/17/18). "Press Release: Seer Debuts with Proprietary Proteomics Platform to Enable Early Detection of Cancer and Neurological Diseases". South San Francisco, CA. 2018-12-17
AMETEK, Inc.. (12/17/18). "Press Release: AMETEK Completes Private Placement Offering. Senior Note Offering of $575 Million Dollars and €75 Million Euros". Berwyn, PA. 2018-12-17
Santhera Pharmaceuticals Holding AG. (12/14/18). "Press Release: Santhera Raises Gross Proceeds of CHF 23.5 Million and Secures Acquisition of Option to Vamorolone Sub-license". Pratteln. 2018-12-14
Kurma Partners. (12/14/18). "Press Release: Kurma Partners Announces the First Closing of Kurma Biofund III". Paris. 2018-12-14
Noxxon Pharma N.V.. (12/14/18). "Press Release: Noxxon Announces Key Findings that NOX-A12 plus Keytruda Induces an Immune Response and Results in Clinical Benefit for Patients". Berlin. 2018-12-14
BRAIN AG. (12/14/18). "Press Release: BRAIN Achieves Double-digit Growth in Total Operating Performance and Revenues in the 2017/18 Financial Year". Zwingenberg. 2018-12-14
Orchard Therapeutics Ltd.. (12/14/18). "Press Release: Orchard Therapeutics and Sirion Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency". Boston, London & Martinsried. 2018-12-14
Third Rock Ventures, LLC. (12/13/18). "Press Release: Third Rock Ventures Names Christoph Lengauer, Ph.D., and Jeffrey Tong, Ph.D., as Partners". Boston, MA. 2018-12-13
Orchard Therapeutics Ltd.. (12/13/18). "Press Release: Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California". Boston, MA & London. 2018-12-13
Minoryx Therapeutics S.L.. (12/13/18). "Press Release: Minoryx Therapeutics Announces Early Completion of Patient Randomization in the ADVANCE Trial – a Phase 2/3 Clinical Study of MIN-102 in X-ALD Patients". Mataró, Barcelona. 2018-12-13
Bruker Corporation. (12/13/18). "Press Release: Bruker and Mestrelab Announce Strategic Collaboration and Partnership for Chemistry and Pharma Software Applications". Billerica, MA. 2018-12-13
Curetis N.V.. (12/13/18). "Press Release: Curetis Sharpens Focus on Near-term Strategic Value Drivers. Business Focus on U.S. Commercialization, Strategic Partnering, Ares Genetics and Asset Monetization". Amsterdam, Holzgerlingen & San Diego, CA. 2018-12-13
c-LEcta GmbH. (12/13/18). "Press Release: Successful Transformation into a Product Company in 2018 with a Promising Outlook for 2019". 2018-12-13
Lead Discovery Center GmbH. (12/13/18). "Press Release: LDC and the University of Duisburg-Essen Receive EUR 905,000 for the Development of New Therapies for Age-related Blindness". Dortmund. 2018-12-13
AC Immune S.A.. (12/12/18). "Press Release: AC Immune and Lilly Announce License and Collaboration Agreement". Lausanne & Indianapolis, IN. 2018-12-12
Santhera Pharmaceuticals Holding AG. (12/12/18). "Press Release: Santhera Announces Financial Results for the First Nine Months of 2018". Pratteln. 2018-12-12
SGS S.A.. (12/12/18). "Press Release: SGS Invests in Imprint Analytics, Austria". 2018-12-12
Synthace Ltd.. (12/12/18). "Press Release: Computer Aided Biology Pioneer Synthace Secures $25.6 Million in Series B Funding". London. 2018-12-12
Carmat S.A.. (12/12/18). "Press Release: Carmat Announces the Appointment of Pascale d’Arbonneau as Chief Financial Officer". Paris. 2018-12-12
BRAIN AG. (12/11/18). "Press Release: Global Beverage Company Joins BRAIN’s Newly Established FRESCO Program for Nature-based Preservation Ingredients". Zwingenberg & Potsdam. 2018-12-11
Arix Bioscience plc. (12/11/18). "Press Release: Arix Appoints Dr Christian Schetter as Entrepreneur In Residence (EIR)". London. 2018-12-11
Alligator Bioscience AB. (12/11/18). "Press Release: Alligator Bioscience Starts Clinical Phase I Study with ATOR-1015. A First-in-class Bispecific CTLA-4 Antibody". Lund. 2018-12-11
Oxford BioTherapeutics Ltd.. (12/11/18). "Press Release: Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody Platform for Five Bispecific Antibody Programs for up to $450 Million". Shanghai & Oxford. 2018-12-11
Gilead Sciences, Inc.. (12/10/18). "Press Release: Gilead Sciences Names Daniel O’Day Chairman and Chief Executive Officer". Foster City, CA. 2018-12-10
Novartis AG. (12/10/18). "Press Release: Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O to Treat Opioid Use Disorder". Holzkirchen. 2018-12-10
1 2 3 ... 167 168 169  next pagenext page



Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top